MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation
Open Access
- 17 June 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 20 (6) , e1011970
Abstract
Reactivation from latency plays a significant role in maintaining persistent lifelong Epstein-Barr virus (EBV) infection. Mechanisms governing successful activation and progression of the EBV lytic phase are not fully understood. EBV expresses multiple viral microRNAs (miRNAs) and manipulates several cellular miRNAs to support viral infection. To gain insight into the host miRNAs regulating transitions from EBV latency into the lytic stage, we conducted a CRISPR/Cas9-based screen in EBV+ Burkitt lymphoma (BL) cells using anti-Ig antibodies to crosslink the B cell receptor (BCR) and induce reactivation. Using a gRNA library against >1500 annotated human miRNAs, we identified miR-142 as a key regulator of EBV reactivation. Genetic ablation of miR-142 enhanced levels of immediate early and early lytic gene products in infected BL cells. Ago2-PAR-CLIP experiments with reactivated cells revealed miR-142 targets related to Erk/MAPK signaling, including components directly downstream of the B cell receptor (BCR). Consistent with these findings, disruption of miR-142 enhanced SOS1 levels and Mek phosphorylation in response to surface Ig cross-linking. Effects could be rescued by inhibitors of Mek (cobimetinib) or Raf (dabrafenib). Taken together, these results show that miR-142 functionally regulates SOS1/Ras/Raf/Mek/Erk signaling initiated through the BCR and consequently, restricts EBV entry into the lytic cycle.Keywords
All Related Versions
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 AI143620)
This publication has 65 references indexed in Scilit:
- Multiple early factors anticipate post-acute COVID-19 sequelaeCell, 2022
- Pan-cancer analysis of somatic mutations in miRNA genesEBioMedicine, 2020
- Malaria — how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesisCurrent Opinion in Virology, 2016
- Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNAVirology, 2015
- Regulation of the latent-lytic switch in Epstein–Barr virusSeminars in Cancer Biology, 2014
- MicroRNA‐142 is mutated in about 20% of diffuse large B‐cell lymphomaCancer Medicine, 2012
- EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latencyThe EMBO Journal, 2012
- Viral MicroRNA Targetome of KSHV-Infected Primary Effusion Lymphoma Cell LinesCell Host & Microbe, 2011
- MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cellsFEBS Letters, 2011
- Noninvasive diagnosis of nasopharyngeal carcinoma: Nasopharyngeal brushings reveal high Epstein‐Barr virus DNA load and carcinoma‐specific viral BARF1 mRNAInternational Journal of Cancer, 2006